Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 107(11): 5142-7, 2010 Mar 16.
Article in English | MEDLINE | ID: mdl-20194734

ABSTRACT

Germline mutations in the tumor suppressor gene PTEN (phosphatase and tensin homology deleted on chromosome 10) cause Cowden and Bannayan-Riley-Ruvalcaba (BRR) syndromes, two dominantly inherited disorders characterized by mental retardation, multiple hamartomas, and variable cancer risk. Here, we modeled three sentinel mutant alleles of PTEN identified in patients with Cowden syndrome and show that the nonsense Pten(4-5) and missense Pten(C124R) and Pten(G129E) alleles lacking lipid phosphatase activity cause similar developmental abnormalities but distinct tumor spectra with varying severity and age of onset. Allele-specific differences may be accounted for by loss of function for Pten(4-5), hypomorphic function for Pten(C124R), and gain of function for Pten(G129E). These data demonstrate that the variable tumor phenotypes observed in patients with Cowden and BRR syndromes can be attributed to specific mutations in PTEN that alter protein function through distinct mechanisms.


Subject(s)
Alleles , Gene Knock-In Techniques , Neoplasms/enzymology , Neoplasms/genetics , PTEN Phosphohydrolase/genetics , Animals , Base Sequence , Cell Proliferation , DNA Mutational Analysis , Disease Progression , Embryo Loss/pathology , Embryonic Development , Gene Silencing , Gene Targeting , Genetic Predisposition to Disease , Mice , Molecular Sequence Data , Mutant Proteins/metabolism , Neoplasms/pathology , Organ Specificity , Point Mutation/genetics , Precancerous Conditions/pathology , Protein Stability , Proto-Oncogene Proteins c-akt/metabolism , Tumor Suppressor Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...